Blog

Angiocrine Bioscience Licenses New Stem Cell Technology from Weill Cornell … – Business Wire (press release)

Angiocrine Bioscience Licenses New Stem Cell Technology from Weill Cornell …
Business Wire (press release)
NEW YORK–(BUSINESS WIRE)–Angiocrine Bioscience, Inc. announced today that it has licensed the rights to a new technology developed by a team of researchers at the Ansary Stem Cell Institute at Weill Cornell Medical College. The team was led by Dr.

and more »

2014-08-21 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.